Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
35,253,436
-
Share change
-
-810,754
-
Total reported value
-
$178,752,903
-
Price per share
-
$5.07
-
Number of holders
-
113
-
Value change
-
-$8,412,504
-
Number of buys
-
63
-
Number of sells
-
46
Institutional Holders of PIERIS PHARMACEUTICALS INC - COM (PIRS) as of Q2 2018
As of 30 Jun 2018,
PIERIS PHARMACEUTICALS INC - COM (PIRS) was held by
113 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,253,436 shares.
The largest 10 holders included
BVF INC/IL, ORBIMED ADVISORS LLC, BlackRock Inc., ACADIAN ASSET MANAGEMENT LLC, Tekla Capital Management LLC, Aquilo Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, Prosight Management, LP, MILLENNIUM MANAGEMENT LLC, and ARROWSTREET CAPITAL, LIMITED PARTNERSHIP.
This page lists
113
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.